Skip to main content

Table 1 Comparison of demographic characteristics of the study samples

From: The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma

Variable

Total

Frequency (%)

NLPHL

Frequency (%)

LBCL

Frequency (%)

p

Gender

Male

37 (66.1%)

17 (45.9%)

20 (54.1%)

0.397

Female

19 (33.9%)

11 (57.9%)

8 (42.1%)

Site

Axillary LN

17 (31.5%)

8 (47.1%)

9 (52.9%)

0.412

Cervical LN

17 (31.5%)

12 (70.6%)

5 (29.4%)

Inguinal LN

6 (11.1%)

4 (66.7%)

2 (33.3%)

Para-aortic LN

2 (3.7%)

1 (50.0%)

1 (50.0%)

Submandibular LN

1 (1.9%)

1 (100.0%)

0 (0.0%)

Mandibular LN

1 (1.9%)

1 (100.0%)

0 (0.0%)

Axillary mass

1 (1.9%)

1 (100.0%)

0 (0.0%)

Vertebral lesion

1 (1.9%)

0 (0.0%)

1 (100.0%)

Cervical and axillary LN

1 (1.9%)

0 (0.0%)

1 (100.0%)

Skull mass

1 (1.9%)

0 (0.0%)

1 (100.0%)

Sternal mass

1 (1.9%)

0 (0.0%)

1 (100.0%)

Abdominal mass

1 (1.9%)

0 (0.0%)

1 (100.0%)

Omentum

1 (1.9%)

0 (0.0%)

1 (100.0%)

Ankle mass

1 (1.9%)

0 (0.0%)

1 (100.0%)

Spleen

1 (1.9%)

0 (0.0%)

1 (100.0%)

Brain

1 (1.9%)

0 (0.0%)

1 (100.0%)

  1. LN Lymph node, NLPHL Nodular-lymphocyte predominant Hodgkin’s lymphoma, LBCL Large B-cell lymphoma